Stephan Ringshandl

Stephan Ringshandl

Auto-generated profile, based on publicly available information

Stephan Ringshandl

Department of Medicine, Data Integration Center, Philipps-University Marburg, Marburg, Germany

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2020 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
NKNikolaus Korfhage
Nikolaus Korfhage
MMMarkus Mühling
Markus Mühling
SRStephan Ringshandl
Stephan Ringshandl
ABAnke Becker
Anke Becker
BSBernd Schmeck
Bernd Schmeck
Bernd FreislebenBernd Freisleben
Bernd Freisleben
Detection and segmentation of macrophage cells in fluorescence microscopy images is a challenging problem, mainly due to crowded cells, variation in shapes, and morphological complexity. We present a new deep learning approach for cell detection and segmentation that incorporates previously learned nucleus features. A novel fusion of feature pyramids for nucleus detection and segmentation with feature pyramids for cell detection and segmentation is used to improve performance on a microscopic image dataset created by us and provided for public use, containing both nucleus and cell signals. Our experimental results indicate that cell detection and segmentation performance significantly benefit from the fusion of previously learned nucleus features. The proposed feature pyramid fusion architecture clearly outperforms a state-of-the-art Mask R-CNN approach for cell detection and segmentation with relative mean average precision improvements of up to 23.88% and 23.17%, respectively. To analyze cell infection and changes in cell morphology in fluorescence microscopy images, proper cell detection and segmentation are required. In automated fluorescence microscopy image analysis, the separation of signals in close proximity is a challenging problem. High cell densities or cluster formations increase the probability of such situations on the cellular level. Another limitation is the detection of morphologically complex cells, such as macrophages or neurons. Their indefinite morphology causes identification issues when looking for slight variations of fixed shapes. Compared to merely segmenting cytoplasm, instance-based segmentation is a much harder task, since the assignment of a cell instance identity to every pixel of the image is required. We present a new deep learning approach for cell detection and segmentation that efficiently utilizes the nucleus channel for improving segmentation and detection performance of cells by incorporating previously learned nucleus features. This is achieved by a fusion of feature pyramids for nucleus detection and segmentation. The performance is evaluated on a microscopic image dataset, containing both nucleus and cell signals.

6 July 2024 in Chest
Verified
Journal Article
Open access
BWBarbara Christine Weckler
Barbara Christine Weckler
HPHendrik Pott
Hendrik Pott
ARAlan Race
Alan Race
NJNattika Jugkaeo
Nattika Jugkaeo
KKKapil Karki
Kapil Karki
BSBernd Schmeck
Bernd Schmeck

15 April 2025 in Journal of Medical Internet Research
Verified
Journal Article
Open access
JZJasmin Ziegler
Jasmin Ziegler
MEMarcel Pascal Erpenbeck
Marcel Pascal Erpenbeck
TFTimo Fuchs
Timo Fuchs
ASAnna Saibold
Anna Saibold
PVPaul-Christian Volkmer
Paul-Christian Volkmer
CGChristian Gulden
Christian Gulden
Background: Real-world data (RWD) from sources like administrative claims, electronic health records, and cancer registries offer insights into patient populations beyond the tightly regulated environment of randomized controlled trials. To leverage this and to advance cancer research, 6 university hospitals in Bavaria have established a joint research IT infrastructure. Objective: This study aimed to outline the design, implementation, and deployment of a modular data transformation pipeline that transforms oncological RWD into a Health Level 7 (HL7) Fast Healthcare Interoperability Resources (FHIR) format and then into a tabular format in preparation for a federated analysis (FA) across the 6 Bavarian Cancer Research Center university hospitals. Methods: To harness RWD effectively, we designed a pipeline to convert the oncological basic dataset (oBDS) into HL7 FHIR format and prepare it for FA. The pipeline handles diverse IT infrastructures and systems while maintaining privacy by keeping data decentralized for analysis. To assess the functionality and validity of our implementation, we defined a cohort to address two specific medical research questions. We evaluated our findings by comparing the results of the FA with reports from the Bavarian Cancer Registry and the original data from local tumor documentation systems. Results: We conducted an FA of 17,885 cancer cases from 2021/2022. Breast cancer was the most common diagnosis at 3 sites, prostate cancer ranked in the top 2 at 4 sites, and malignant melanoma was notably prevalent. Gender-specific trends showed larynx and esophagus cancers were more common in males, while breast and thyroid cancers were more frequent in females. Discrepancies between the Bavarian Cancer Registry and our data, such as higher rates of malignant melanoma (3400/63,771, 5.3% vs 1921/17,885, 10.7%) and lower representation of colorectal cancers (8100/63,771, 12.7% vs 1187/17,885, 6.6%) likely result from differences in the time periods analyzed (2019 vs 2021/2022) and the scope of data sources used. The Bavarian Cancer Registry reports approximately 3 times more cancer cases than the 6 university hospitals alone. Conclusions: The modular pipeline successfully transformed oncological RWD across 6 hospitals, and the federated approach preserved privacy while enabling comprehensive analysis. Future work will add support for recent oBDS versions, automate data quality checks, and integrate additional clinical data. Our findings highlight the potential of federated health data networks and lay the groundwork for future research that can leverage high-quality RWD, aiming to contribute valuable knowledge to the field of cancer research.